Displaying drugs 226 - 250 of 409 in total
| Name | Weight | Structure | Desription | Categories |
|---|---|---|---|---|
| Digoxin Immune Fab (Ovine) | 47301.7 C2085H3223N553O672S16 |  | An antibody binding fragment which binds digoxin molecules which is used as an antidote to digoxin overdose. | Antidotes / Immunoglobulin G |
| Pancrelipase lipase | 48000.0 |  | A lipase used to treat pancreatic exocrine insufficiency. | Carboxylic Ester Hydrolases / Lipase |
| Ranibizumab | 48349.6111 C2158H3282N562O681S12 |  | A recombinant humanized monoclonal antibody and VEGF-A antagonist used for the management of macular edema after retinal vein occlusion, age-related macular degeneration (wet), and diabetic macular edema. | Antineovascularisation Agents |
| Etanercept | 51234.9 C2224H3475N621O698S36 |  | A protein therapy based on the binding fragment of the tumour necrosis factor alpha receptor used to treat severe rheumatoid arthritis and moderate to severe plaque psoriasis. | Tumor necrosis factor alpha (TNF-alpha) inhibitors |
| Alefacept | 51801.1 C2306H3594N610O694S26 |  | A recombinant fusion protein that binds CD2 and is used treat moderate to severe plaque psoriasis. | Selective Immunosuppressants |
| Hyaluronidase (ovine) | 53870.9 C2455H3775N617O704S21 |  | A purified form of sheep hyaluronidase enzyme used as an adjunct in subcutaneous rehydration therapy and to increase absorption of other drugs and radiopaque imaging agents. | Enzymes |
| Efgartigimod alfa | 54000.0 |  | A neonatal Fc receptor blocker used to treat generalized myasthenia gravis in patients who are AChR-antibody positive. | Selective Immunosuppressants |
| Blinatumomab | 54100.0 C2367H3577N649O772S19 |  | An antineoplastic antibody used to treat CD19-positive B-cell precursor acute lymphoblastic leukemia (ALL) in relapsed and refractory patients, as well as those in first or second complete remission with minimal residual disease (MRD). | Antibodies, Monoclonal |
| Drotrecogin alfa | 55000.0 C1786H2779N509O519S29 |  | A form of recombinant activated human protein C used to reduce mortality in patients with severe sepsis by inhibiting coagulation Factors V and VIII. | Enzymes |
| Sebelipase alfa | 55000.0 C1968H2945N507O551S15 | | A recombinant lysosomal acid lipase used to treat lysosomal acid lipase deficiency. | Cholesterol Ester Storage Disease, drug therapy / Enzymes / Hydrolytic Lysosomal Cholesteryl Ester-specific Enzyme / Hydrolytic Lysosomal Triacylglycerol-specific Enzyme / Wolman Disease, drug therapy |
| Alglucerase | 55597.4 C2532H3854N672O711S16 |  | A form of recombinant beta-glucocerebrosidase enzyme used to replace the deficient endogenous enzyme in the treatment of Gaucher disease. | Enzymes |
| Imiglucerase | 55597.4 C2532H3854N672O711S16 |  | A form of recombinant human beta-glucocerebrosidase enzyme used to replace the deficient endogenous enzyme in the treatment of Gaucher disease. | Enzyme Replacement Therapy / Enzymes / Gaucher Disease / Hydrolytic Lysosomal Glucocerebroside-specific Enzyme |
| Galsulfase | 56012.6 C2534H3851N691O719S16 |  | A recombinant human enzyme used as replacement enzyme therapy for the treatment of of adults and children with Mucopolysaccharidosis VI, a rare genetic disorder caused by a deficiency of a lysosomal enzyme. | Enzymes / Hydrolytic Lysosomal Glycosaminoglycan-specific Enzyme |
| Taliglucerase alfa | 56637.9397 C2580H3918N680O727S17 | | A hydrolytic lysosomal glucocerebroside specific enzyme, used for long term enzyme replacement therapy in patients with Type 1 Gaucher disease. | Enzyme Replacement Therapy / Enzymes / Gaucher Disease / Hydrolytic Lysosomal Glucocerebroside-specific Enzyme |
| Pancrelipase amylase | 57086.0 |  | A lipase used to treat pancreatic exocrine insufficiency. | Amylases / Amylases, antagonists & inhibitors / Glycoside Hydrolases |
| Denileukin diftitox | 57647.3 C2560H4042N678O799S17 |  | A recombinant cytotoxic protein based on a combination of diphtheria toxin fragments and interleukin-2 used to treat cutaneous T-cell lymphoma by targeting the interleukin-2 receptor. | Antineoplastic Agents |
| Tagraxofusp | 57695.0 C2553 H4026 N692 O798 S16 |  | A CD123-directed cytotoxin used to treat blastic plasmacytoid dendritic cell neoplasm. | CD123 Interaction / Cytotoxins |
| Tenecteplase | 58951.2 C2561H3919N747O781S40 |  | A modified form of recombinant human tissue plasminogen activator used in the emergency treatment of myocardial infarction and pulmonary emboli. | Enzymes |
| Coagulation factor X human | 59000.0 |  | A coagulation factor used to treat Factor X deficiency to control bleeding. | Blood Coagulation Factors / Enzyme Precursors / Factor X / Factor X, agonists |
| Alteplase | 59000.0 C2569H3928N746O781S40 |  | A recombinant form of human tissue plasminogen activator used in the emergency treatment of myocardial infarction, ischemic stroke, and pulmonary emboli. | Enzymes |
| Romiplostim | 59000.0 C2634H4086N722O790S18 | | A fusion protein thrombopoietin (TPO) peptide analog that increases platelet counts by binding to and activating the human TPO receptor. Used to treat thrombocytopenia associated with chronic immune thrombocytopenia (ITP). | Receptors, Thrombopoietin, agonists / Thrombopoietin Receptor Agonist |
| Anistreplase | 59042.3 C2569H3928N746O781S40 |  | A form of recombinant human tissue plasminogen activator used in the emergency treatment of myocardial infarction and pulmonary emboli. | Enzymes |
| Dulaglutide | 59669.81 C2646H4044N704O836S18 |  | A GLP-1 agonist used to manage type 2 diabetes mellitus. | Glucagon-like peptide-1 (GLP-1) analogues |
| Peginterferon alfa-2a | 60000.0 |  | A modified form of recombinant human interferon used to stimulate the innate antiviral response in the treatment of hepatitis B and C viruses. | Antiviral Agents / Drug Carriers / Interferon alpha / Interferons |
| Ropeginterferon alfa-2b | 60000.0 C16H29N3O6(C2H4O)n(C2H4O)n |  | A mono-pegylated type I interferon used to treat polycythemia vera. | Interferons |
Displaying drugs 226 - 250 of 409 in total